Cargando…

β‐Blockade attenuates renal blood flow in experimental endotoxic shock by reducing perfusion pressure

Clinical data suggests that heart rate (HR) control with selective β1‐blockers may improve cardiac function during septic shock. However, it seems counterintuitive to start β‐blocker infusion in a shock state when organ blood flow is already low or insufficient. Therefore, we studied the effects of...

Descripción completa

Detalles Bibliográficos
Autores principales: van Loon, Lex M., Rongen, Gerard A., van der Hoeven, Johannes G., Veltink, Peter H., Lemson, Joris
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6900489/
https://www.ncbi.nlm.nih.gov/pubmed/31814327
http://dx.doi.org/10.14814/phy2.14301
_version_ 1783477363561988096
author van Loon, Lex M.
Rongen, Gerard A.
van der Hoeven, Johannes G.
Veltink, Peter H.
Lemson, Joris
author_facet van Loon, Lex M.
Rongen, Gerard A.
van der Hoeven, Johannes G.
Veltink, Peter H.
Lemson, Joris
author_sort van Loon, Lex M.
collection PubMed
description Clinical data suggests that heart rate (HR) control with selective β1‐blockers may improve cardiac function during septic shock. However, it seems counterintuitive to start β‐blocker infusion in a shock state when organ blood flow is already low or insufficient. Therefore, we studied the effects of HR control with esmolol, an ultrashort‐ acting β1‐selective adrenoceptor antagonist, on renal blood flow (RBF) and renal autoregulation during early septic shock. In 10 healthy sheep, sepsis was induced by continuous i.v. administration of lipopolysaccharide, while maintained under anesthesia and mechanically ventilated. After successful resuscitation of the septic shock with fluids and vasoactive drugs, esmolol was infused to reduce HR with 30% and was stopped 30‐min after reaching this target. Arterial and venous pressures, and RBF were recorded continuously. Renal autoregulation was evaluated by the response in RBF to renal perfusion pressure (RPP) in both the time domain and frequency domain. During septic shock, β‐blockade with esmolol significantly increased the pressure dependency of RBF to RPP. Stopping esmolol showed the reversibility of the impaired renal autoregulation. Showing that clinical diligence and caution are necessary when treating septic shock with esmolol in the acute phase since esmolol reduced RPP to critical values thereby significantly reducing RBF.
format Online
Article
Text
id pubmed-6900489
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-69004892019-12-20 β‐Blockade attenuates renal blood flow in experimental endotoxic shock by reducing perfusion pressure van Loon, Lex M. Rongen, Gerard A. van der Hoeven, Johannes G. Veltink, Peter H. Lemson, Joris Physiol Rep Original Research Clinical data suggests that heart rate (HR) control with selective β1‐blockers may improve cardiac function during septic shock. However, it seems counterintuitive to start β‐blocker infusion in a shock state when organ blood flow is already low or insufficient. Therefore, we studied the effects of HR control with esmolol, an ultrashort‐ acting β1‐selective adrenoceptor antagonist, on renal blood flow (RBF) and renal autoregulation during early septic shock. In 10 healthy sheep, sepsis was induced by continuous i.v. administration of lipopolysaccharide, while maintained under anesthesia and mechanically ventilated. After successful resuscitation of the septic shock with fluids and vasoactive drugs, esmolol was infused to reduce HR with 30% and was stopped 30‐min after reaching this target. Arterial and venous pressures, and RBF were recorded continuously. Renal autoregulation was evaluated by the response in RBF to renal perfusion pressure (RPP) in both the time domain and frequency domain. During septic shock, β‐blockade with esmolol significantly increased the pressure dependency of RBF to RPP. Stopping esmolol showed the reversibility of the impaired renal autoregulation. Showing that clinical diligence and caution are necessary when treating septic shock with esmolol in the acute phase since esmolol reduced RPP to critical values thereby significantly reducing RBF. John Wiley and Sons Inc. 2019-12-09 /pmc/articles/PMC6900489/ /pubmed/31814327 http://dx.doi.org/10.14814/phy2.14301 Text en © 2019 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of The Physiological Society and the American Physiological Society. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Research
van Loon, Lex M.
Rongen, Gerard A.
van der Hoeven, Johannes G.
Veltink, Peter H.
Lemson, Joris
β‐Blockade attenuates renal blood flow in experimental endotoxic shock by reducing perfusion pressure
title β‐Blockade attenuates renal blood flow in experimental endotoxic shock by reducing perfusion pressure
title_full β‐Blockade attenuates renal blood flow in experimental endotoxic shock by reducing perfusion pressure
title_fullStr β‐Blockade attenuates renal blood flow in experimental endotoxic shock by reducing perfusion pressure
title_full_unstemmed β‐Blockade attenuates renal blood flow in experimental endotoxic shock by reducing perfusion pressure
title_short β‐Blockade attenuates renal blood flow in experimental endotoxic shock by reducing perfusion pressure
title_sort β‐blockade attenuates renal blood flow in experimental endotoxic shock by reducing perfusion pressure
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6900489/
https://www.ncbi.nlm.nih.gov/pubmed/31814327
http://dx.doi.org/10.14814/phy2.14301
work_keys_str_mv AT vanloonlexm bblockadeattenuatesrenalbloodflowinexperimentalendotoxicshockbyreducingperfusionpressure
AT rongengerarda bblockadeattenuatesrenalbloodflowinexperimentalendotoxicshockbyreducingperfusionpressure
AT vanderhoevenjohannesg bblockadeattenuatesrenalbloodflowinexperimentalendotoxicshockbyreducingperfusionpressure
AT veltinkpeterh bblockadeattenuatesrenalbloodflowinexperimentalendotoxicshockbyreducingperfusionpressure
AT lemsonjoris bblockadeattenuatesrenalbloodflowinexperimentalendotoxicshockbyreducingperfusionpressure